{
  "schema_version": "0.4",
  "ir_kind": "hl",
  "metadata": {
    "title": "Neural Induction",
    "source": {
      "type": "paper",
      "id": "s41596-025-01197-x.pdf"
    }
  },
  "resources": {
    "materials": [
      {
        "id": "m1",
        "name": "dorsomorphin",
        "concentration": "4 μM"
      },
      {
        "id": "m2",
        "name": "SB-431542",
        "concentration": "10 μM"
      },
      {
        "id": "m3",
        "name": "neurobasal media",
        "supplements": [
          "B27"
        ]
      }
    ],
    "containers": [],
    "equipment": [],
    "samples": [],
    "data": []
  },
  "protocol": {
    "steps": [
      {
        "id": "s1",
        "op": "annotate",
        "inputs": [],
        "outputs": [],
        "params": {},
        "annotations": {
          "description": "We use the dual-SMAD inhibitors dorsomorphin (4 μM) and SB-431542 (10 μM) in neurobasal media with the vitamin A-containing B27 supplement for neural induction (Figs. 1 and 2a–c)."
        }
      }
    ],
    "start_step_id": "s1",
    "edges": [
      {
        "from": "s1",
        "to": "s1"
      }
    ],
    "detail_level": 0
  }
}